Open Access

Table 3

KAP third quartile value and E presented in this study compared to the literature.

  KAP (Gycm2) E (ICRP 103) (mSv) (Laura 2015) (DCCEa)



Procedure Name Present study Ref Present study Ref Present Study NCRP 160 (NCRP Report 160) Associated Error (%)
Coronary percutaneous transluminal angioplasty, stent placement, or radiofrequency ablation 29.8 26.0 (Kicken, Kemerink, and van Engelshoven 1999) 6.9 6.4 (Kicken, Kemerink, and van Engelshoven 1999) 0.2315 0.2600 –10.94%
Lower limb arteriography 59.7 68.0 (Arthur et al., 2002) 6.1 6.8 (Arthur et al., 2002) 0.1022 0.1000 2.18%
Head and/or neck angiography 163.9 14.1 (Li et al., 2020) 11.5 1.2 (Li et al., 2020) 0.0702 0.0870 –19.35%
Coronary angiography (diagnostic) 58.0 25.8 (Kicken, Kemerink, and van Engelshoven 1999) 5.2 3.1 (Kicken, Kemerink, and van Engelshoven 1999) 0.0897 0.1200 –25.29%
Pelvic vein embolization 220.7 282.2 (Li et al., 2020) 59.8 71.4 (Li et al., 2020) 0.2710 0.2530 7.11%
Thoracic angiography of pulmonary artery or aorta 457.5 284.2 (Li et al., 2020) 89.3 73.9 (Li et al., 2020) 0.1952 0.2600 –24.93%
Abdominal angiography or aortography 98.1 284.2 (Li et al., 2020) 30.5 73.9 (Li et al., 2020) 0.3109 0.2600 19.58%
Transjugular intrahepatic portosystemic shunt placement 25.4 108.1 (Li et al., 2020) 8.6 28.1 (Li et al., 2020) 0.3386 0.2600 30.22%

KAP, Kerma-Area Product (Gy · cm2); E, Effective Dose (mSv); Cf, Conversion Factor (Sv/Gy); DCCE, dose conversion coefficient from KAP to E (mSv Gy−1 cm−2)

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.